Background: Patients with advanced cancer may benefit from End of Life (EOL) planning but there is evidence that their willingness and desire to engage in advance care planning (ACP) varies. The reasons for this remain poorly understood. Previous reviews on ACP most commonly report outcome measures related to medical interventions and type of care. Synthesis of the literature which aims to illuminate the salient characteristics of ACP and investigates the psychological and social features of preparation for the EOL, is required.
Studies have found that the responses to ACP of cancer patients, and the values and needs they express, differ from other patient populations [4] . There is evidence that patients with advanced cancer vary in their willingness and desire to engage in ACP discussions and often refuse to participate in ACP research [5] . Factors identified as contributing to low documented use of ACP in cancer patients include: a wide age range, unpredictable disease trajectories[6{Kiely, 2011 #3521]}, and equivocal treatment options. Low ACP uptake in cancer patients may also relate to poor understanding of treatment intent [7] and the desire to maintain hope. [4, 8] It is not completely clear why ACP has failed to become a part of routine care, and questions remain as to whether ACP is even able to meet its objectives when implemented. [9] [10] [11] [12] In this regards it is noteworthy that a recent systematic review concluded that while there is some evidence that ACP positively impacts the quality of end-of-life care, further research is needed which focuses on the experiences of patients and their families when undertaking ACP. [13] There have been no reviews which report on the views or experiences of stakeholders with regards to ACP. There has also been no synthesis of the ACP literature which focuses specifically on cancer patients. This paper aims to address this gap and to further our understanding of how stakeholders approach ACP by examining the literature exploring patient, caregiver and healthcare professional experiences and perceptions of ACP in cancer care. This review aimed to take a broad perspective on the ACP literature by including both quantitative and qualitative literature.
A data extraction form developed by Powell et al. [16] was used to extract data using a standard format (authors, year, country, approach, design, method, sample and setting, measures, results and summary). For both qualitative and quantitative papers a thematic content analysis was conducted. The results and summary were prepared by extracting themes or categories of data using the terms used in the paper itself and a summary of the relevant material.
Quality assessment:
The quality of included studies was assessed using the standardized Qualsyst tool [17] . Qualsyst consists of two separate, manualised scoring systems; one for qualitative studies and one for quantitative studies. Two reviewers assessed all studies separately. Cohen's Kappa, used to determine inter-rater reliability, was 0.438 between the two raters; indicating moderate agreement according to Landis and Koch's standards for interpretation [18] . Any identified discrepancies were resolved through iterative discussions. Each study was allocated a final score by consensus, which, as defined by Lee et al. [10] , was used to define the quality of the study as: limited (<50%), adequate (50-70%), good (71-80%), or strong (score of >80%). The quality ratings for each included study are reported in Tables 4-8 , summary of studies by theme. For further information on quality scoring, see Kmet et al. [17] Data synthesis Thematic content analysis was used to organize and summarise the empirical evidence. [19] 1 All tables are located at the end of this document.
One author (SJ) developed textual descriptions, which were tabulated in the data extraction summary form. Two authors developed a preliminary list of descriptive themes to identify the main, recurrent and/or most important themes and/or concepts across multiple studies. Four authors engaged in a process of iterative discussion to generate conceptual themes that helped to explain the phenomena being described in the literature, constantly comparing the themes being developed against the data. All four authors engaged in continual dialogue to help introduce a range of perspectives.
Results
The search strategy produced 2483 references. After deletion of duplicates and eligibility assessment, 40 studies were included (19 quantitative, 17 qualitative, 4 mixed methods)(see Figure 1) . The included studies reported data from eight countries. This included the USA (19) , UK (8) , Europe (5), Australia (5), Taiwan (1) and one study from Canada (which was reported in two papers).
Themes
Five primary themes were identified from the literature: ACP is relational, ACP provokes fear and distress, Autonomy is conceptually complex and contested, Institutional culture is influential in ACP and Knowledge of ACP and previous healthcare experiences can act as motivator or barrier to ACP. A summary of the classification of included articles according to theme is provided in Table 3 .
Theme 1: ACP is relational
Family is a motivator or barrier to ACP
Seventeen studies [3-5, 8, 20-31] reported on the role or influence of the family or caregivers in ACP. Refer to Table 3 for details of studies. Four studies examined the experiences and perceptions of caregivers only, a further 6 studies included caregivers in the participant groups.
Between 36% and 47% [27] [32] [30] [22] of people with cancer wanted to involve their family in decision making regarding their current or future healthcare. Some preferred to make decisions on their own [32] and some indicated that making their EOL treatment wishes clear with an AD would have no impact on their family. [21] For some, including family in EOL decision making raised concerns over upsetting or placing undue stress or burden on family members. [8] Others reported difficulty initiating conversations with their family, with some reporting particular difficulties arising when their expectations or fears differed from those of other family members [4] . But family can also act as a motivator for ACP [33] , with patients who had signed an advance directive often being of the view that ADs might ease the burden of decision-making on relatives and facilitate the physician's decision. [23] Indeed, the literature on ACP makes it clear that the majority of patients with cancer consider the welfare of their family members when deciding whether or not to participate in ACP and that where they choose to engage in ACP with their family members, they generally approach it as a shared experience with loved ones. [21, 23, [27] [28] [29] [30] [5] [3] [25] [20]
The therapeutic relationship
The majority of studies [21, 22, 24, 25, 29, [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] addressed the relationship between patients and health professionals in some way with 16 studies describing the perspectives of patients or caregivers and 6 the views of health professionals.
Physicians generally described the importance of developing rapport with patients in opening up discussions about ACP [41] noting "palliative care as an art not a science, based on relationships". [42] Where physicians reported time and privacy as barriers to ACP, they did so because they believed these were fundamental to establishing relationships with patients and families. [39, 40] Further, some health professionals expressed concerns that ACP may damage their relationships with patients and were concerned that formal ACP "did not take account of professional-patient relationships and individual patient needs." [42] Patients generally preferred to do ACP with the physician who knows them best [20] , preferred that their physicians initiated discussion regarding ACP and were more likely to participate in ACP or draw up an advance directive if they had discussed this with their oncologist [34] , suggesting that the explicit or implicit endorsement of ACP by the patient's principal health professional caregiver may be influential.
Theme 2: ACP may provoke fear and distress
Much of the literature on ACPs has focused on patient, caregiver and health professional views on ACP and on its implementation (see Table 3 for relevant references). While results vary across studies and between stakeholders, in general terms ACP is viewed as desirable [2, 5, 24, 25, 29, 31, 34, 37, 38, 42, [45] [46] [47] , although some have concerns over the capacity of ACP to meet its objectives. [23, 42, 45] However, even amongst those who supported ACP, there was concern regarding at least some components of ACP. Most notably concerns surrounding when ACP should be initiated and by whom, as well as concerns over providing or receiving information regarding the EOL. Often this concern was based on fears that ACP would be distressing, either for the patients themselves or for their loved ones. Patients and families identified tensions between wanting to discuss ACP and getting on with life as usual. [28, 38] A proportion of participants in most studies experienced fear or distress surrounding ACP. [5, 29, 31, 48] 
Timing of ACP discussions
Of the practical challenges raised by ACP, one of the most contested surrounds the optimal timing for initiation of discussions regarding EOL care. Sixteen studies explicitly [4, 5, 21, 25, 27, 28, 30, 35, 38, 39, 42, 45, 46, [49] [50] [51] ] addressed this question. Only one study supported the introduction of ACP early in the course of a patients illness trajectory. [39] In almost all studies patients and health professionals preferred to delay the introduction of ACP to later in the illness trajectory, when patients are unwell, have a major change in functional status, or when treatment options have been exhausted. [4, 25, 28, 30, 42, 46, [49] [50] [51] [52] This reflected a belief that if ACP were initiated at an earlier time-point, patients would simply not be "unwell enough" for ACP. [21, 25, 27] Introducing ACP later in a patients illness trajectory was also considered to allow patients to focus on living in the present by 'carrying on as normal' whilst they still felt reasonably well [5, 30, 38] and "allow patients to enjoy what is left of their remaining lives". [42] In one study patients reported that "discussion held around the time of diagnosis or active treatment may be inappropriate, and do more harm than good" [28] . Some studies endorsed an individualized approach to the timing of ACP and or discussion of different components at different times. [5, 27, 35, 45] For example, in one study, the option that physicians should broach the subject when and if they consider it appropriate was the most popular response. [35] Overall, the literature suggest that all stakeholders are reluctant to initiate ACP early and prefer to delay ACP until the issues raised, particularly those surrounding preferences for EOL care, are more clinically relevant and appear more 'real', or more salient.
Initiation of ACP discussions
Thirteen studies addressed initiation of ACP [27, 28, 34, 35, 39, 41, 42, 44, 45, 49, 50, 52] . In almost all studies participants expected an individual or group other than themselves to initiate ACP, with most believing that physicians were responsible for initiating discussions regarding ACP.
Studies involving nurses reported that they believed that a wide range of 'other' persons should initiate ACP discussions, including physicians, patients, social workers, care coordinators or other pastoral care providers. [39, 44] Patients almost universally preferred that their physician initiated ACP discussions. [27, 28, 41 , 52] Studies reporting physicians' attitudes to initiation of ACP were contradictory. In two studies physicians directly rejected the responsibility for initiating discussion of advance directives or ACP, preferring to delegate this to either the patient or their family members. [35, 41] In other studies, physicians acknowledged that they did have a responsibility for initiating ACP discussions but suggested that these discussions should be prompted by implicit cues from the patient indicating that they wished to discuss ACP. [41, 42, 45, 51] Physician preference for a diffusion of responsibility regarding EOL decision-making was expressed across several themes in the results. Whilst the reasoning behind this is understandable (in sensitivity to patients' readiness to discuss EOL topics) [24, 35, 41, 45, 51] it is incongruent with the clear expectations of other ACP stakeholders that physicians should and will initiate ACP discussions.
Information about EOL care
Twenty-four studies addressed information about EOL [3-5, 21, 22, 25, 27-30, 32, 34, 40-42, 46-49, 51, 52] . These reveal enormous variability in the amount of information that patients and caregivers wish to hear in relation to EOL issues. [4, 43, 46] A large proportion of patients want information regarding the EOL, however many described tensions between wanting to be involved in decision-making regarding their medical care and discomfort discussing EOL. [28, 29, 32, 34, 38, 48] For example, in one study, some said "there were things they would appreciate discussing but they also wanted to be able to close the topic down again". [28] In another study almost a quarter of participants said that ACP discussions gave them new information which was challenging, but valuable. [27] In contrast, some patientparticipants strongly rejected ACP, preferring not to discuss what may happen in the future or think about "gory details". [25, 30] It was thought that such discussions could cause confusion or distress [30] , increase feelings of hopelessness, or interfere with a person's optimism about their illness. [5, 25, 33] Health professionals and caregivers also appeared reluctant to discuss EOL for fear of causing distress, taking away hope or touching on topics that the patient is not ready to engage with. [41] [42] [43] 51] But although both patients and health professionals commonly expressed fears that ACP may disrupt hope, the results suggest that this is not necessarily the case [2, 22, 33] . In one study, despite 73% of participants having undertaken ACP, 69% believed they could beat their cancer. [22] 
Setting for ACP discussions
There is very limited literature dealing with stakeholders' preferences for the setting in which to conduct ACP, and those studies that have explored this issue likely reveal more about the existing institutional practices of the participants involved than any rich insight into the optimal setting for ACP.
Unsurprisingly, oncologists appear to most commonly initiate EOL discussion in outpatient clinics [49] and nurses appear to support ACP in a wide range of settings, including both prehospital admission, admission and inpatient settings. [22, 25, 44 , 49] Two studies explored patient preference for where ACP should be conducted. In these two studies, 58% [25] and 87% [20] of patients supported a policy in which discussion regarding ADs was offered as part of the hospital admissions process.
Theme 3: Autonomy is conceptually complex and contested
1 ACP is controlled by physicians
It was explicitly and implicitly expressed across the literature that physicians feel they are best placed to determine when patients are ready for ACP, and what should be discussed. While few studies explicitly addressed the fact that physicians effectively 'control' ACPpossessing both expert knowledge about a patient's diagnosis, prognosis and treatment options as well as professional power relating to the timing, structure and content of EOL discussions and ACP -references to the power of the physician and the degree of control they exerted over the patient, and over other health professionals, particularly nurses, permeated the literature on ACP. Twelve studies [21, 24, 27, 28, 34, 36, 39, 42, 43, 46, 50, 53] addressed this topic . In one study, nurses felt that they needed more autonomy to initiate ACP discussions "without doctors' permission or repercussions from doctors for doing so". [39] In another study "physician is reluctant" "physician is rushed" "physician delays the discussion" and "physician discusses other treatment options" were the most commonly reported barriers to ACP [24] . In one study patients and caregivers explicitly acknowledged physician discomfort in discussing and initiating EOL conversations as a barrier to participating in discussions. [46] 3. 2 Patient, caregiver and healthcare professionals views regarding autonomy
Patients' views
In contrast to the assumptions that are often said to justify ACP, patients rarely discussed ACP in terms of their control or influence over their treatment choices. Indeed only two studies, both quantitative studies that offered participants restricted response options, reported that patients felt that EOL discussion would help them to establish or maintain control over their healthcare. [23, 33] Instead, patients tended to speak of ACP in terms of the social, psychological and emotional issues that arise when one approaches the end of one's life. [31] Furthermore, patients tended not to regard ACP principally as a means by which they could control decision-making regarding their healthcare beyond the point at which they lose capacity. A number of studies reported that patients accepted that their wishes may vary during the course of their illness, that their expressed preferences for care may not always be followed, and that family members or health professionals would use their own judgment in deciding whether their stated preferences should be followed, [3, 5, 38] and were happy to delegate treatment decisions to trusted professionals. [27, 28, 30, 31, 48] 
Caregivers' views
Only one qualitative study specifically explored caregiver's views regarding the role of ACP in actualizing autonomy. [8] This study described how caregivers tended to acknowledge patients' future care wishes while also developing subsidiary plans. For the caregivers in this study, fulfilling patients' wishes was only one of a number of the perceived functions or benefits of ACP and "whereas caregivers mostly expected to honor their interpretations of patients' ''implied'' wishes, others said that they would override the patient's plans if they felt that it was in the patient's and family's best interest."
Health professional's views
In contrast to patients and caregivers, health professionals often viewed the primary function of ACP to be the documentation of treatment choices. In one study, 73.9% of physicians defined EOL discussion as the discussion about code status, advance directives, withholding treatment when recommended by the physician and transitioning to hospice care.
[49] In another study most nurses believed that ADs alone (without conversation) were effective to communicate patients' wishes for EOL care. [24] In other words, for health professionals ACP served principally as a form of documentation of information, rather than as a communicative tool or as a mechanism for reinforcing or deepening the health professional-patient relationship. The rationale that health professionals gave for this stance was that the documentation of advance treatment preferences was a method of empowering patients. Advance directives were spoken of as prescriptive instructions from patients, which should be respected and upheld, by health professionals [36, 39] and caregivers. [36, 45] Health professionals admitted to having concerns regarding ACP in regard to caregivers' wishes or decision making conflicting with written directives [45] , with health professionals expressing the belief that in these situations they had a (moral) responsibility not only to refrain from interfering with a written course of action, but to advocate for the patient where necessary by preventing others from interfering [36, 45] . In a UK study, legislation was seen as supporting this position: "we've got a lot more say in what is going to happen, the patients got a lot more say in what is going to happen, rather than the caregiver". [45] Theme 4 Institutional culture is influential in ACP Five studies examined the institutional culture surrounding ACP [36, 39, 40, 42, 45] , all studies involved health professionals. Although "institutional policies were seen as a way of encouraging and supporting the implementation of AD's" [39] they also raised concerns for health professionals.[42, 45] "Overly prescriptive" and "tick box" approaches to ACP were generally seen as hindering, rather than supporting good quality EOL care [42] . Institutionalized ACP processes and ACP documentation were felt to insufficiently reflect the reality of conversations with patients about EOL care, or the practicalities of how knowledge is actually shared between health professionals and patients.
[45] As a result many health professionals admitted to preferring more individualized, informal methods of care planning with their patients. More discursive and less structured ACP discussions with colleagues who shared responsibility for the care of particular patients was preferred to communication that they believed was based around documentation and was excessively bureaucratic. [40, 42, 45] Theme 5 Knowledge of ACP and previous healthcare experiences can act as a motivator or barrier to ACP Six studies [2, 3, 5, 32, 36, 46, 50, 54] reported that patients' experience of healthcare and perception of the healthcare system, as well as their previous experiences with dying people could positively or negatively influence their support for and willingness to engage in ACP. [2, 3, 8, 30, 32, 46] Health professionals' knowledge of and attitudes towards ACP was also consistently found to be an important factor in their willingness to initiate or participate in ACP. [39, 50, 54] Discussion Advance Care Planning is generally championed as a means by which competent patients can extend their involvement in, and control of decisions regarding their own health care beyond the point at which they lose capacity as a result of illness or injury. This review of empirical studies of ACP in cancer care suggests that while ACP may function as a decisional 'tool', its' uptake and utility is much more a function of a range of complex relational, emotional and social factors. The literature here suggests that ACP is relational, meaning it is enacted less as an individual directive, and more as a family centered and social process. ACP also provokes fear and distress. It is seen to carry both benefits and risks -social, psychological and emotional risks -all of which may impact upon the behavior of patients, family members and health professionals surrounding ACP. The behavior and choices of patients, their loved ones and the staff caring for them in relation to the end of life are strongly influenced by the institutional culture within which they are operating, as well as their previous experiences of the healthcare setting or the dying process. ACP is therefore not simply a manifestation of a patient's choice but the result of a complex and dynamic interplay between patients and their healthcare providers. The enactment of ACP is embedded within a healthcare system already inscribed by professional organizational and interpersonal power structures. ACP has emerged from existing ideas about healthcare, decision-making and the proper role of patients, their families and those who care for them. Within this context, facilitating patient autonomy is neither simple nor uncontested.
Autonomy has long been privileged as the preeminent principle in Western legal and bioethical thought and is the concept that underpins decision-making in health care and consent. [55, 56 ] ACP, at least as it is commonly understood by health professionals, is based upon the individualistic conceptualization of autonomy, whereby rational agents can assert their control over their own healthcare and enforce their right to non interference, most usually from excessive medical treatment at the EOL, through documentation of their care preferences and appointment of their nominated proxy.
The literature in this review suggests that this model of autonomy may not represent the reality of ACP or be appropriate to its actualization. An alternative model of autonomyrelational autonomy -emphasizes the fact that individual autonomy is socially dependent: that is, the capacity and opportunity for autonomous action is dependent on our particular social relationships and the power structures in which we are embedded. [57, 58] Under this model, simply presenting patients (or the health professionals responsible for their care) with an authorized mechanism for communication and for documenting a patient's preferences for EOL care may do little to optimize care or advance the patient's autonomy. Instead, what is required is a clear recognition that whether or not patients choose to engage in decision-making, the choices they make and their capacity to implement their choices are all dependent on existing relationships with family and health professionals, as well as the healthcare context within which they are operating. "Autonomy requires more than freedom from interference; it requires that one's relationships with particular individuals and institutions be constituted in such a way as to give one genuine opportunities for choice".
[59] Thus, where the relational, emotional and social factors necessary for successful ACP are not in place, patients will not be able to meaningfully participate in ACP and it will either fail or become simply a function of the need of institutions or professionals to 'get something on paper'. So, for example, if families are reluctant to participate then patients are likely to refuse ACP; if physicians are ignorant of ACP or concerned about the negative impacts it may have on patients then they are unlikely to encourage patients to pursue it; and if the social and healthcare environment in which patients are being treated emphasizes the unilateral authority of doctors or fails to create the time and space for ACP in different contexts then patients will be unable to actively and meaningfully engage in the process.
The data reported here support one of the criticisms that has been made against ACP, i.e. that while ACP is best regarded as a process of communication which incorporates goals, values and wishes, in practice ACP remains strongly linked to an advance directive framework. That is, the key aim of ACP programs within healthcare is to "improve and support advance directives use through providing a supportive framework".
[55] Unlike health professionals, patients and their families may not see autonomy over treatment decisions as the key aspect of ACP and may not even desire a process which is concerned principally with the documentation and enforcement of previously expressed wishes for treatment. Further to this, patients may not consider non-fulfillment of their wishes by trusted professionals and loved ones to be a violation of their autonomy, but rather as a manifestation of their love and/or care. If this is the case, the social and healthcare environment may not only work against patients achieving ACP but may conflict with the needs of patients who desire it. The evidence suggests that ACP may have more to do with shared decision-making and communication than with avoidance of excessive medical treatment at the EOL, and more to do with relationships and trust than with liberty and rights. This being the case, as others have noted, the "use of standardized ACP approaches may need revisiting as they may fail to appreciate how personal, shared lives, and culturally related expectations and/or beliefs inform how patients and caregivers consider, develop, and enact on plans". [5] Limitations of this review While a review of empirical research into ACP in cancer care yields some important insights, there are sufficient limitations in the published data that great care must be taken in translating the results described here to specific populations.
First, the majority of ACP research has been conduced in the United States (19 of 40) or Europe (13 of 40) and almost all has been conducted within the tertiary care setting. Few studies have been conducted in outpatient or community care settings and only limited attention has been given to cross-cultural considerations in end-of-life care planning.
[55] In a recent systematic review of 113 studies providing empirical evidence regarding ACP, only nine studies were performed in the community [13] . For the papers included in this review only two studies [29, 33] specifically considered ethnic differences in EOL care preferences. As a consequence, little is known about the attitudes of different ethnic or cultural groups to ACP and the findings reported here can only really be regarded as applicable to patients from Western Europe and North America.
Perhaps more importantly, however, methodological limitations raise real questions about the veracity of the findings reported here. Many of the studies failed to report detail on screening, response rates and recruitment procedures. Many of the studies were also crosssectional studies of perceptions and few involved patients in the terminal phases of their illness. Given what we know about the dynamic and complex nature of treatment preferences and the ways in which attitudes may change during the course of one's illness [60] , such studies are unlikely to adequately reflect the perceptions that patients have about EOL care as their death approaches. And finally, it seems likely that there are systematic differences between those who choose to participate in ACP research and those who choose not to participate. For example, those who experience high levels of distress surrounding EOL discussions are unlikely to participate in ACP research. Therefore their perspective is notably missing from the ACP literature. This raises the possibility that the support for ACP reported in these studies over-represents support for ACP in patients with cancer and those who care for them.
Conclusion:
While there is broad support for discussing EOL care, both among patients with cancer and those who care for them, the notion that ACP is concerned principally with the 'right' to selfdetermination through control over treatment choices at the end-of-life may misrepresent the way that ACP actually occurs in cancer care, undermine the principle of ACP and ultimately conflict with the deeper concerns and needs of patients, who experience ACP as relational, emotional and social. Further research is needed to examine the ethical framework within which ACP is being conducted and to further understand the philosophical approach of healthcare professionals, cancer patients and their caregivers to ACP. 
ACP:
Original research that explored ACP was eligible. Advance care planning was defined as 'formalised discussion between patients and healthcare providers which may include family members or friends, with possible outcome of formal documentation of EOL care wishes'. This included studies exploring advance directives with reference to a process of discussion with health professionals. We excluded studies that focus exclusively on the documentation of wishes regarding cardiopulmonary resuscitation.
Types of studies:
Quantitative or qualitative studies were eligible for inclusion. This included studies utilising: interviews/ focus groups, surveys and consultation audits (audio-taped ACP discussions). Case studies, conference abstracts, editorials, commentary and reviews and papers published in languages other than English were excluded.
Types of participants: people with cancer and/or their family members and/or health professionals caring for this group, in any setting, was included. Studies focusing on children (<18 years) and people with mental illness other than dementia were excluded.
Where samples included patients with other primary diagnosis, they were included only if greater than 50% of participants had a primary diagnosis of cancer and results for this sub group was reported separately. Participants placed a great deal of importance on the development of communication skills so that could be of help to patients. It was clear from their responses that they believed more time was needed to increase their ability to assist patients with ADs. Nurses who provided an explanation referred to the need for more time to spend establishing relationships (rapport) with patients and their families. Respondents expressed a clear desire to be informed and to take part in the decisionmaking process: 58% wanted to be constantly informed, 91% wanted to decide about treatment options with the medical staff (with or without their family) and 84% wanted detailed information on the drugs they are administered.
Mixed Methods Studies
Barakat, A et al. 
Sample: 68 completed surveys
Response rate: 68% (68 of 100) Setting: Inpatients in the oncology and blood and marrow transplantation units.
Only a minority of patients (29%) had an EOL discussion with their oncologist and for those that did the majority initiated that conversation, not their doctor. The option that physicians should broach the subject of advance directives for medical care when and if they consider it appropriate was the most popular in all groups. The majority in all groups rejected the expectation that physicians should initiate a discussion about advance directives as a matter of routine, most rigorously by physicians themselves. They were prepared to do this only if they considered it to be appropriate as a result of the individual situation. They would much rather delegate this initiative to other people, usually to the patient's relatives. Participants felt that it important to understand patients' decisions. Participants, however, diverged on which components were needed, optimal times for related discussions, and whether decisions needed discussion or documentation. HCPs tended to rely on patients to explicitly raise issues for discussion rather than initiate these them. At the same time they were alert to cues from the patient or guided by intuition as to when to introduce issues around EOLC, what depth to go into and so on. HCP's were often hesitant to take a lead over concerns about causing distress, taking away hope or touching on topics that the patient was not ready to engage with.
Carrion I et al. Most appreciated the information they had been given and being provided with answers to their questions. Carers reaction to the ACP intervention varied, some were grateful for the opportunity to discuss the future, others preferred not to think ahead and to live "one day at a time". People preferred to focus on living in the present by 'carrying on as normal' whilst they still felt reasonably well. Planning ahead for dying or death was reported as being 'morbid' Patients talked about the prognosis being an educated guess or a 'mind game'. Some people reported not wanting to live with a death sentence and others talked about not wanting to know their prognosis, feeling that knowing would damage their ability to focus on the positive. . Laryionava K et al. Health-care professionals differed considerably in their understanding of when to initiate discussions about forgoing cancer-specific therapy at the EOL. However, their views could be consolidated into three approaches: (1) preparing patients gradually throughout the course of disease, (2) waiting until the patient him/herself starts the discussion about forgoing cancer specific treatment, and (3) waiting until all tumour specific therapeutic options are exhausted.Discussions tended to be initiated when all cancer-specific treatments had been exhausted or when therapy failed or brought about severe complication.. Hope was about possibilities not expectations. All dyads spontaneously identified hope for cure in relation to their current plan of care. The dyads found the ACP interview helpful, important and although very emotional, most found it easier than they anticipated. These individuals were able to sustain multiple hopes, including hope for cure, at the same time as choosing "do not resuscitate" option should their heart or breathing stop. Many participants expressed concerns about role-related issues.
-"Nurses wanted physicians to communicate clearly and realistically prognosis, therapy choices, chance of response, potential side effects and non treatment options."
Mixed Methods Studies
Cox K et al. A small number of mostly black patients did feel that a living will would increase their feeling of hopelessness and would decrease the quality of medical care that they would receive at the end of their lives (18% and 14% respectively of black patients) Samara J et al. 29 
2013
Australia QN 45% QL 55%
Mixed methods study -qualitative plus Pre-and postimplementation audit Method: Focus group plus delivery of a an education programme on ACP either in face to face sessions or via an e-learning package plus pre and post session written questionnaires.
Sample: 25 nurses
Response rate: Not reported Setting: Oncology department of a public hospital
The participants reported that ACP should be the responsibility of hospital medical officers, the patient's GP, social workers and care coordinators. Some advocated for a designated ACP team. The participants also suggested that as some patients preferred to arrange the advance care privately themselves rather than openly talking about it with the hospital staff that this should be encouraged and supported. 15% would have the discussion regarding prognosis only if the patient/family brings it up. Physicians were more likely to wait for the patient family to bring up preferred place of death than to have the conversation "now" (24% vs. 21%).
49% reported that they would wait to discuss hospice until there were no more nonpalliative treatments, and similarly 29% for DNR discussion.
Surgeons and medical oncologists were more likely than noncancerous specialists to report discussing prognosis 'now', but non-cancer specialists were more likely than cancer specialists to discuss DNR status, hospice, and preferred site of death 'now'. Participants felt that it important to understand patients' decisions to help fulfil patients' wishes, and allow patients some control. Participants, however, diverged on whether decisions needed discussion or documentation. Whereas caregivers mostly expected to honour their interpretations of patients' ''implied'' wishes, 'others said that they would override patients' plans if they felt that it was in the patients' and families' best in-interest. Many nurses said they needed the support of their physicians. The nurses stated that they needed collaborative working relationships with physicians and that they needed to be included in the discussions with patients when prognoses and ADs were discussed. The themes that emerged from the 37 participants who had living wills included "to make sure things are taken care of, and to have final control over decisions about terminal care". Lack of knowledge about treatment options and a lack of collaboration between primary and secondary care physicians were identified as a particular problem for GPs caring for cancer patients.
Mixed Methods Studies
Boyd K et al. There were general concerns about formal processes being overly prescriptive and difficult to achieve. Participants prefer a more individualised, non-formal method of care planning with their patients. They believed that record keeping does not accurately reflect the reality of conversations, or the practicalities of how knowledge is actually shared between HCP's. They prefer to maintain discretion on when EOL discussions/ decision-making should occur. Cross-sectional study Method: multi-centre survey using a structured questionnaire mailed to participant's respondents were assigned to "participation" group, or to "non-participation" group.

Authors
Sample: 413 HCP completed questionnaires
Response rate: 71.8% (431 of 600 responded). 18 incomplete questionnaires excluded. Setting: Healthcare professionals including doctors and nurses working at oncology care wards or palliative care units.
"Workplace (hospice vs. non-hospice)", "attitudes that the enactment of Natural Death Act would contribute to promoting the use of advance directives" and "knowledge about Natural Death Act" are the three most important independent factors that affect healthcare professionals' decision to execute or initiate discussion about ADs.
Hwang, S et al. There are significant disparities between racial groups in advance care planning, knowledge, attitudes and decision-making. 
